Exicure (XCUR) Other Non-Current Liabilities (2016 - 2026)
Exicure (XCUR) reported Other Non-Current Liabilities of $5.8 million for Q1 2026, up 7.28% on a YoY basis from $5.4 million in Q1 2025, and down 0.52% quarter-over-quarter from $5.8 million in Q4 2025.
Exicure (XCUR) Other Non-Current Liabilities (2016 - 2026) Analysis & Trends
Exicure has reported Other Non-Current Liabilities for 8 years, with the latest figure at $5.8 million in Q1 2026.
- For the quarter ending Q1 2026, Other Non-Current Liabilities rose 7.28% year-over-year to $5.8 million; the trailing twelve-month figure through Mar 2026 stood at $5.8 million (up 7.28% YoY), and the FY2025 full-year result was $5.8 million, changed N/A from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $5.8 million, down from $5.8 million in the prior quarter.
- The five-year high for Other Non-Current Liabilities was $5.8 million in Q4 2025, with the low at $5.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.77 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 5.55 Mn |
| Jun 30, 2025 | 5.31 Mn |
| Mar 31, 2025 | 5.38 Mn |
| Dec 31, 2021 | 656,000.00 |
| Sep 30, 2021 | 656,000.00 |
| Jun 30, 2021 | 656,000.00 |
| Mar 31, 2021 | 656,000.00 |
| Dec 31, 2020 | 656,000.00 |
| Mar 31, 2020 | 42,000.00 |
| Sep 30, 2019 | 144,000.00 |
| Jun 30, 2019 | 541,000.00 |
| Mar 31, 2019 | 380,000.00 |
| Dec 31, 2018 | 797,000.00 |
| Sep 30, 2018 | 42,000.00 |
| Jun 30, 2018 | 1.57 Mn |
| Mar 31, 2018 | 277,000.00 |
| Dec 31, 2017 | 278,000.00 |
| Dec 31, 2016 | 281,000.00 |